DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Patrick Van Katwijk - 2 Novavax - 2 Mayank Mamtani - 2 Silvia Taylor - 2 Taylor - 2 Mamtani - 2 Jefferies - 2 Roger Song - 2
Top related locs:
The Hague Netherlands U.S Schwenksville , Pennsylvania Somerville , Massachusetts Krakow Poland Maryland
Top related orgs:
Dutch Health Service Organization - 2 Getty - 2 Pfizer - 2 Moderna - 2 Riley Securities - 2 CNBC - 2 FDA - 2 Drug Administration - 1

Search resuls for: "Silvia Taylor"


2 mentions found


☆ Novavax's updated Covid vaccine can still catch up to Pfizer, Moderna shots this fall
  + stars: | 2023-10-07 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +6 min
The biotech company is banking on sales of its updated Covid vaccine — its only commercially available product — and a broad cost-cutting push to help it stay afloat. Novavax's shot fends off the virus with protein-based technology, a decades-old method used in routine vaccinations against hepatitis B and shingles. The federal government shifted Covid vaccine distribution and coverage to the private market for the first time this fall. A sign advertises COVID-19 (coronavirus) vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, August 14, 2023. Some pharmacies, like Walgreens , also appear to be resolving supply disruptions, which left many stores without any new Covid shots for patients to receive.
Persons: Patrick Van Katwijk, Novavax, aren't, Mayank Mamtani, fends, Silvia Taylor, Taylor, Novavax's, Mamtani, Hannah Beier, Jefferies, Roger Song, Brian Snyder, Biden Organizations: Dutch Health Service Organization, Getty, Pfizer, Moderna, Drug Administration, Riley Securities, CNBC, Covid, FDA, Bloomberg, Insurance, Walgreens, Reuters Locations: The Hague, Netherlands, U.S, Schwenksville , Pennsylvania, Somerville , Massachusetts
☆ Covid vaccine maker Novavax sees a pathway to survival – but it won’t be easy
  + stars: | 2023-06-14 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +10 min
Jakub Porzycki | NurPhoto | Getty ImagesNovavax has a clear message for Wall Street: The cash-strapped Covid vaccine maker sees a pathway to survival. The 36-year-old company will continue to rely on its protein-based Covid vaccine – its only commercially available product – for most of its revenue this year. Once the U.S. government's supply of free Covid vaccines runs out, all three companies will sell updated shots directly to health-care providers. A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. But Taylor emphasized that the plan will help Novavax refocus on its top priority: delivering an updated vaccine in the coming months.
Persons: Jakub Porzycki, Novavax, Covid, Cowen, Brendan Smith, John Jacobs, Smith, that's, Silvia Taylor, Taylor, Jefferies, Roger Song, Patrick Van Katwijk, Mayank Mamtani, let's, Mamtani, Let's, Song, Ding Genhou Organizations: NurPhoto, Getty, Pfizer, Moderna, CNBC, Food and Drug Administration, World Health Organization, FDA, Dutch Health Service Organization, Riley Securities, U.S, Centers for Disease Control, CDC, Reuters, Visual China Locations: Krakow, Poland, Maryland, U.S, The Hague, Netherlands, Moderna, Geneva, Hohhot, Inner Mongolia Autonomous Region, China
0 next >>
Total: 2